Is Eli Lilly Stock A Buy After Slashing The Price Of Its New Weight-Loss Drug?
In this article:
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?